Stock 1541 IMMUNEONCO BIOPHARMACEUTICALS (SHANGHAI) INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions ImmuneOnco Biopharmaceuticals (Shanghai) Inc.

Equities

1541

CNE100006624

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:22 2024-05-10 am EDT 		5-day change 1st Jan Change
14.58 HKD -2.15% Intraday chart for ImmuneOnco Biopharmaceuticals (Shanghai) Inc. -1.09% -51.24%
Apr. 17 ImmuneOnco Obtains Chinese Nod for Phase III Trials of Anti-Cancer Medication MT
Apr. 17 ImmuneOnco Biopharmaceuticals Inc. Receives Approval from the National Medical Products Administration of the People's Republic of China for the Protocol of the Phase Iii Clinical Trial of IMM01 CI

Turnover - Change in analysts' estimates

EBIT - Change in analysts' estimates

Dividend / Share (DPS) - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

EBIT

Dividend / Share (DPS)

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. 1541 Stock
  4. Revisions ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW